M. abscessus Biobank Study | Personalized Phage Therapy Research Opportunity

Research Opportunity - Mab Biobank for Phage Therapy Development

Tolka AI Therapeutics is building a biobank specifically for Mycobacterium abscessus to advance personalized bacteriophage therapy research. This IRB-approved study (BRANY#25-08-468-1945) aims to collect Mab isolates that could lead to personalized treatment options.

What We're Doing: We're collecting sputum samples from Mab patients to isolate bacteria for phage discovery. If we find active phages against your specific Mab strain, you could potentially access personalized phage therapy through future clinical trials or expanded access programs.

Participation Details:
● Two sputum samples collected at home
● All materials and shipping provided (no cost)
● Brief medical history questionnaire
● Optional monthly QOL-B surveys

You're Eligible If:
● 18+ years old
● Live in the US
● Have Mab documented from respiratory specimens
● Can safely produce sputum

This is a unique opportunity to contribute to research that could directly benefit you and the broader M abscessus community.

Sign up or learn more: tolka.ai/biobank

Questions: [email protected]